Fig. 5From: Trovafloxacin attenuates neuroinflammation and improves outcome after traumatic brain injury in miceTrovafloxacin treatment reduces CD68 protein expression levels at 6 days post-injury. Representative western blots showing CD68 protein levels expressions at 6 days post-injury in sham or CCI-injured mice treated with vehicle or trovafloxacin (TVX). Graph shows densitometric quantification of CD68 is represented in each group (n = 5 per group). Values are represented as mean ± SEM. Two-way ANOVA followed by Tukey’s HSD test was used to determine statistical significance. *p < 0.01, sham vs. CCI group; **p < 0.01, CCI vehicle vs. CCI + TVXBack to article page